Abstract
It is clear that we need a viable, strong, active and even interventionist FDA. But we also need new antibiotics. How did we get to a place where these two obvious needs might be in conflict?
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Shlaes, D.M. (2010). The FDA. In: Antibiotics. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9057-7_4
Download citation
DOI: https://doi.org/10.1007/978-90-481-9057-7_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9056-0
Online ISBN: 978-90-481-9057-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)